|
Revlimid
Hi Caregiver,
Revlimid is an oral immunomodulatory drug, approved for MDS with del 5q chromosome abnormality. In non del 5q MDS, the response is betwen 20%-25%Some forum members with non del5q are responding to this drug and are transfusion independent.
Since the response rate is low, its a personal choice between trying it or staying with supportive care, i.e. transfusions.
All the Best!!
__________________
Mother age 79, dx MDS RCMD low risk del 20q April 2013, no response to EPO, Danazol. pRBC tx dependent - 2 units every 3-4 weeks, exjade Dec 2013 - Mar2014, restarted Dec 2014
|